GeneDx Reports Third-Quarter 2026 Financial Results
GeneDx Holdings reported financial results for the third quarter of 2026.
Story updates
09:06:00 PM UTC
SquawkNews
GeneDx reported unaudited third-quarter 2026 financial results and updated its 2026 guidance, including guidance for Q4. The supplied release text does not include the results or guidance figures.Material DetailsContext by AI AnalystThis is a quarterly earnings update, but the supplied text omits t…
GeneDx Holdings Corp. (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the third quarter of 2026.“Our Q3 results reflect profitable execution in a growing market, as we translate the rising demand for…